Inogen Inc (INGN) CFO Alison Bauerlein Sells 3,192 Shares

Inogen Inc (NASDAQ:INGN) CFO Alison Bauerlein sold 3,192 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $125.41, for a total value of $400,308.72. Following the completion of the sale, the chief financial officer now directly owns 8,808 shares in the company, valued at approximately $1,104,611.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Alison Bauerlein also recently made the following trade(s):

  • On Friday, February 16th, Alison Bauerlein sold 8,808 shares of Inogen stock. The shares were sold at an average price of $125.03, for a total value of $1,101,264.24.
  • On Wednesday, February 14th, Alison Bauerlein sold 9,737 shares of Inogen stock. The shares were sold at an average price of $120.05, for a total value of $1,168,926.85.
  • On Friday, February 9th, Alison Bauerlein sold 11,718 shares of Inogen stock. The shares were sold at an average price of $115.87, for a total value of $1,357,764.66.
  • On Monday, February 12th, Alison Bauerlein sold 27,630 shares of Inogen stock. The shares were sold at an average price of $116.46, for a total value of $3,217,789.80.

Shares of Inogen Inc (NASDAQ INGN) traded up $2.38 during trading hours on Tuesday, hitting $126.84. The stock had a trading volume of 129,770 shares, compared to its average volume of 132,699. Inogen Inc has a one year low of $67.34 and a one year high of $130.05. The firm has a market cap of $2,600.00, a price-to-earnings ratio of 87.03, a PEG ratio of 4.05 and a beta of 1.02.

Several brokerages have recently weighed in on INGN. Piper Jaffray Companies raised Inogen from a “neutral” rating to an “overweight” rating in a report on Tuesday. Zacks Investment Research raised Inogen from a “hold” rating to a “buy” rating and set a $135.00 price objective on the stock in a report on Monday. Finally, BidaskClub raised Inogen from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $103.71.

Several large investors have recently made changes to their positions in the company. MetLife Investment Advisors LLC acquired a new stake in shares of Inogen during the 4th quarter worth approximately $957,000. Gotham Asset Management LLC bought a new position in shares of Inogen during the 4th quarter worth approximately $863,000. Jane Street Group LLC bought a new position in shares of Inogen during the 4th quarter worth approximately $243,000. Meadow Creek Investment Management LLC lifted its position in shares of Inogen by 26.0% during the 4th quarter. Meadow Creek Investment Management LLC now owns 2,576 shares of the medical technology company’s stock worth $307,000 after buying an additional 532 shares during the period. Finally, Raymond James & Associates bought a new position in shares of Inogen during the 4th quarter worth approximately $244,000.

TRADEMARK VIOLATION WARNING: “Inogen Inc (INGN) CFO Alison Bauerlein Sells 3,192 Shares” was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.thelincolnianonline.com/2018/02/20/inogen-inc-ingn-cfo-alison-bauerlein-sells-3192-shares.html.

About Inogen

Inogen, Inc is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device.

Insider Buying and Selling by Quarter for Inogen (NASDAQ:INGN)

Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply